EUVIMEDEUVIMED entdecken
Open Access

Quantitative [ 89 Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI

Ameer Mansur, Jonathan E McConathy, Erica Stringer-Reasor, Gabrielle Rocque, Katia Khoury, Noon Eltoum, Moozhan Nikpanah, Jennifer Bartels, Brian Wright, Nusrat Jahan, Denise Jeffers, Suzanne E Lapi und 1 weitere

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.268931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Ameer Mansur und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama. Hauptthemen laut MEDLINE: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Diffusion Magnetic Resonance Imaging, Trastuzumab. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesDiffusion Magnetic Resonance ImagingTrastuzumabPositron-Emission TomographyZirconiumHumansFemaleMiddle AgedNeoplasm MetastasisAdultAgedMultimodal ImagingRadioisotopesAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

DW-MRIHER2 PET/MRIHER2-positive metastatic breast cancer[89Zr]Zr-trastuzumabmultiparametric

Substanzen

Erb-b2 Receptor Tyrosine KinasesTrastuzumabZirconiumRadioisotopesAntibodies, Monoclonal, HumanizedERBB2 protein, humanzirconium-89-trastuzumab

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
  • O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama.
  • Department of Radiology, University of Alabama, Birmingham, Alabama.
  • Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama; and.
  • O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama; agsorace@uab.edu lapi@uab.edu.
  • Department of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama.

Förderung

  • NCI NIH HHS

Zitieren

APA

Mansur, A., McConathy, J. E., Stringer-Reasor, E., Rocque, G., Khoury, K., Eltoum, N., Nikpanah, M., Bartels, J., Wright, B., Jahan, N., Jeffers, D., Lapi, S. E., & Sorace, A. G. (2025). Quantitative [ 89 Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268931

Vancouver

Mansur A, McConathy JE, Stringer-Reasor E, Rocque G, Khoury K, Eltoum N, et al. Quantitative [ 89 Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268931

BibTeX
@article{Mansur2025,
  author = {Mansur, Ameer and McConathy, Jonathan E and Stringer-Reasor, Erica and Rocque, Gabrielle and Khoury, Katia and Eltoum, Noon and Nikpanah, Moozhan and Bartels, Jennifer and Wright, Brian and Jahan, Nusrat and Jeffers, Denise and Lapi, Suzanne E and Sorace, Anna G},
  title = {Quantitative [ 89 Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.268931}
}
Kostenlos starten →